• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Healthcare, Regulatory and Reimbursement Landscape - Denmark - Product Image

Healthcare, Regulatory and Reimbursement Landscape - Denmark

  • ID: 2366174
  • December 2012
  • Region: Denmark
  • 191 pages
  • GlobalData

Healthcare, Regulatory and Reimbursement Landscape - Denmark

Summary

GlobalData, the industry analysis specialist, has released its new report, “Healthcare, Regulatory and Reimbursement Landscape - Denmark”. The report is an essential source of information and analysis on Denmark`s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and healthcare infrastructure. Most importantly, it provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets.

The report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by Our team of industry experts.

In 2011, the population of Denmark was 5.6 million. The population of Denmark is increasing due to a positive net migration and positive balance of birth rate to mortality rate. Denmark policymakers are now presented with the problems of a declining population of the working age group and an increasing elderly population. The country’s pharmaceutical market was READ MORE >

Note: Product cover images may vary from those shown

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Report Guidance
3 Overview of the Pharmaceutical and Medical Device Market
3.1 Pharmaceutical Market
3.1.1 Market Overview
3.1.2 Supply Channels
3.1.3 Market Segments
3.1.4 Overview of Major Therapeutic Areas
3.1.5 Major Players
3.2 Medical Device Market
3.2.1 Market Overview
3.2.2 Overview of the Top Five Segments
3.2.3 Major Players
3.3 Market Drivers and Barriers
3.3.1 Drivers
3.3.2 Barriers
4 Market Access
4.1 Reimbursement and Payer Landscape
4.1.1 Overview of Healthcare System
4.1.2 Reimbursement Process
4.1.3 Overview of Insurance Providers
4.1.4 Patient’s Share in Healthcare Spending
4.1.5 Drug Price Trends
4.1.6 Pricing Policies
4.2 Regulatory Landscape
4.2.1 Overview of Regulatory Agencies
4.2.2 Market Authorization Procedure for Pharmaceutical Products
4.2.3 New Medical Device Approval Process
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing
4.2.5 Exports and Imports
4.2.6 Intellectual Property Rights
4.2.7 Clinical Trial Regulations
4.2.8 Pharmaceutical Advertising Regulations
4.2.9 Pharmacy Regulations
4.2.10 Labeling and Packaging Regulations
5 Country Analysis
5.1 Political Environment
5.1.1 Political Structure
5.1.2 Analysis of Current Political Environment
5.1.3 Healthcare Policy Initiatives
5.2 Economic Landscape
5.3 Economic Indicators
5.3.1 Gross Domestic Product
5.3.2 Gross National Income
5.3.3 Inflation
5.3.4 Currency Exchange Rate
5.3.5 Foreign Direct Investment
5.3.6 Foreign Exchange Reserves
5.3.7 Trade Balance
5.3.8 General Government Structural Balance
5.3.9 General Government Gross Debt
5.3.10 External Debt
5.3.11 Major Industries
5.4 Demographics
5.4.1 Population
5.4.2 Education and Literacy
5.4.3 Employment
5.4.4 Disease Burden
5.5 Healthcare Infrastructure
5.5.1 Healthcare Facilities
5.5.2 Healthcare Parameters
5.5.3 Environmental Health
5.5.4 Healthcare Personnel
5.6 Healthcare Expenditures
5.6.1 Overview
5.6.2 Major Components of Healthcare Spending
5.6.3 Share of Public and Private Sectors
5.6.4 Pharmaceutical and Healthcare R&D Expenditures
5.7 Trade Associations
5.7.1 The Danish Association of the Pharmaceutical Industry
5.7.2 Association of Danish Pharmacies
5.7.3 The Danish Generic Medicines Industry Association
5.7.4 Danish Medical Association
5.8 Trade Fairs
6 Opportunities and Challenges
6.1 Opportunities
6.2 Challenges
7 Appendix
7.1 Abbreviations
7.2 Bibliography
7.3 Methodology
7.3.1 Coverage
7.3.2 Secondary Research
7.3.3 Forecasting
7.3.4 Primary Research
7.3.5 Expert Panel Validation
7.4 Contact Us
7.5 Disclaimer

1.1 List of Tables
Table 1: Pharmaceutical Market, Denmark, Revenue ($bn), 2005-2010
Table 2: Pharmaceutical Market, Denmark, Revenue Forecast ($bn), 2011-2020
Table 3: Price Margins of Distribution Channel (%), Denmark, 2011
Table 4: Generic Pharmaceutical Market, Denmark, Revenue ($m), 2005-2010
Table 5: Drugs Going off Patent, Global, Revenue ($bn), 2011-2015
Table 6: Over-the-Counter Drugs Market, Denmark, Revenue ($m), 2006-2010
Table 7: Major Therapeutic Areas, Denmark, Revenue ($m), 2010
Table 8: Nervous System Drugs Market, Denmark, Revenue ($m), 2006-2010
Table 9: Anti-Cancer Drugs Market, Denmark, Revenue ($m), 2006-2010
Table 10: Anti-Infectives Market, Denmark, Revenue ($m), 2006-2010
Table 11: Respiratory Drugs Market, Denmark, Revenue ($m), 2006-2010
Table 12: Gastrointestinal Drugs Market, Denmark, Revenue ($m), 2006-2010
Table 13: Major Products, Novo Nordisk, Global, Revenue ($m), 2011
Table 14: Late-Stage Pipeline, Novo Nordisk, 2012
Table 15: Major Products, Takeda, Global, Revenue ($m), 2011
Table 16: Late-Stage Pipeline, Takeda, 2012
Table 17: Major Products, Lundbeck, Global, Revenue ($m), 2011
Table 18: Late-Stage Pipeline, Lundbeck, 2012
Table 19: Major Products, LEO Pharma, Global, 2011
Table 20: Late-Stage Pipeline, LEO Pharma, 2012
Table 21: Medical Device Market, Denmark, Revenue ($bn), 2006-2011
Table 22: Medical Device Market, Denmark, Revenue Forecast ($bn), 2012-2020
Table 23: Medical Device Market, Denmark, Segments, Revenue ($m), 2011
Table 24: In-Vitro Diagnostics Market, Denmark, Revenue ($m), 2006-2011
Table 25: In-Vitro Diagnostics Market, Denmark, Revenue Forecast ($m), 2012-2020
Table 26: Sales Trends for Major Players, In-Vitro Diagnostics, Denmark, 2010
Table 27: Orthopedic Devices Market, Denmark, Revenue ($m), 2006-2011
Table 28: Orthopedic Devices Market, Denmark, Revenue Forecast ($m), 2012-2020
Table 29: Sales Trends for Major Players, Orthopedic Devices, Denmark, 2011
Table 30: Ophthalmic Devices Market, Denmark, Revenue ($m), 2006-2011
Table 31: Ophthalmic Devices Market, Denmark, Revenue Forecast ($m), 2012-2020
Table 32: Sales Trends for Major Players, Ophthalmic Devices, Denmark, 2010
Table 33: Diagnostic Imaging Devices Market, Denmark, Revenue ($m), 2006-2011
Table 34: Diagnostic Imaging Devices Market, Denmark, Revenue Forecast ($m), 2012-2020
Table 35: Sales Trends for Major Players, Diagnostic Imaging Devices, Denmark, 2010
Table 36: Cardiovascular Devices Market, Denmark, Revenue ($m), 2006-2011
Table 37: Cardiovascular Devices Market, Denmark, Revenue Forecast ($m), 2012-2020
Table 38: Sales Trends for Major Players, Cardiovascular Devices, Denmark, 2011
Table 39: Major Medical Device Companies, Denmark, Revenue ($m), 2010
Table 40: Major Products, Siemens, Global, Revenue ($m), 2010
Table 41: Major Products, Roche, Global, Revenue ($m), 2010
Table 42: Late-Stage Pipeline, Roche, 2012
Table 43: Major Products, Medtronic, Global, Revenue ($m), 2011
Table 44: Late-Stage Pipeline, GE Healthcare, 2012
Table 45: Major Products, Abbott, Global, Revenue ($m), 2010
Table 46: Applications for General Reimbursement Approval, Denmark, 2008-2011
Table 47: Reimbursement Thresholds, Denmark, 2012
Table 48: Benefits Covered by “Health Insurance Denmark,” Denmark, 2012
Table 49: Healthcare Spending, Denmark, Out-of-Pocket Expenditure (%), 2005-2010
Table 50: Change in Average Price of Drugs (%), Denmark, 2006-2011
Table 51: Net Assessment Times and Clock Stop Periods, Denmark, 2012
Table 52: GDP per Capita ($), Denmark, 2006-2011
Table 53: GDP per Capita ($), Denmark, Forecast, 2012-2020
Table 54: GDP ($bn), Denmark, 2006-2011
Table 55: GDP ($bn), Denmark, Forecast, 2012-2020
Table 56: GDP, Denmark, Annual Growth (%), 2006-2011
Table 57: GNI per Capita ($), Denmark, 2006-2011
Table 58: Average Consumer Price Index, Denmark, 2006-2011
Table 59: Average Consumer Price, Denmark, Annual Change (%), 2006-2011
Table 60: Average Consumer Price, Denmark, Annual Change (%), Forecast, 2012-2020
Table 61: Currency Exchange Rate (DKK/$), Denmark, 2006-2011
Table 62: Foreign Direct Investment ($bn), Denmark, 2006-2011
Table 63: Foreign Exchange Reserves ($bn), Denmark, 2006-2011
Table 64: Exports of Goods and Services ($bn), Denmark, 2006-2011
Table 65: Imports of Goods and Services ($bn), Denmark, 2006-2011
Table 66: General Government Structural Balance ($bn), Denmark, 2006-2011
Table 67: General Government Structural Balance ($bn), Forecast, Denmark, 2012-2020
Table 68: General Government Gross Debt (% of GDP), Denmark, 2005-2010
Table 69: External Debt ($bn), Denmark, 2006-2011
Table 70: Major Industries, Denmark, Gross Value Added ($bn), 2010-2011
Table 71: Population (m), Denmark, 2006-2011
Table 72: Population (m), Denmark, Forecast, 2012-2020
Table 73: Urban and Rural Population, Denmark, Share (%), 2006-2011
Table 74: Urban and Rural Population, Denmark, Share (%), Forecast, 2012-2020
Table 75: Age Groups, Denmark, Population Distribution (%), 2006-2011
Table 76: Age Groups, Denmark, Population Distribution (%), Forecast, 2012-2020
Table 77: Births (per 1,000 Population), Denmark, 2006-2011
Table 78: Mortality (per 1,000 Population), Denmark, 2006-2011
Table 79: Major Causes of Mortality, Denmark, 2010
Table 80: Infant Mortality, Denmark, Mortality Rate (per 1,000 Live Births), 2005-2010
Table 81: Immunization Rate for DPT, Measles (%), Denmark, 2005-2010
Table 82: Major Causes of Male Mortality, Denmark, 2010
Table 83: Major Causes of Female Mortality, Denmark, 2010
Table 84: Gender Ratio (M/F), Denmark, 2006-2011
Table 85: Life Expectancy at Birth (Years), Denmark, 2005-2010
Table 86: Life Expectancy at Birth (Years), Denmark, Forecast, 2011-2020
Table 87: Students, Denmark, Gross Enrollment (%), 2005-2010
Table 88: Unemployment Rate (%), Denmark, 2005-2010
Table 89: Major Causes of Hospitalization, Denmark, Male Patients (per 1,000 Population), 2010
Table 90: Major Causes of Hospitalization, Denmark, Female Patients (per 1,000 Population), 2010
Table 91: Major Diseases, Denmark, DALYs (per 100,000 Population), 2004
Table 92: Number of Hospitals, Denmark, 2005-2010
Table 93: Diagnostic Equipment Units (per 1,000,000 Population), Denmark, 2006-2011
Table 94: Hospital Beds (per 1,000 Population), Denmark, 2005-2010
Table 95: Physicians (per 1,000 Population), Denmark, 2005-2010
Table 96: CO2 Emissions (kilotons), Denmark, 2005-2010
Table 97: PM10 (Micrograms per Cubic Meter), Denmark, 2005-2010
Table 98: Healthcare Personnel (per 1,000 Population), Denmark, 2005-2010
Table 99: Healthcare Expenditures (% of GDP), Denmark, 2005-2010
Table 100: Healthcare Expenditures, Denmark, Share of Major Components (%), 2010
Table 101: Healthcare Expenditures, Denmark, Public-Private Share (%), 2005-2010
Table 102: R&D Expenditures ($bn), Denmark, 2006-2011
Table 103: Major Healthcare Trade Fairs, Denmark, 2012

1.2 List of Figures
Figure 1: Pharmaceutical Market, Denmark, Revenue ($bn), 2005-2010
Figure 2: Pharmaceutical Market, Denmark, Revenue Forecast ($bn), 2011-2020
Figure 3: Pharmaceutical Distribution Channel, Denmark, 2012
Figure 4: Generic Pharmaceutical Market, Denmark, Revenue ($m), 2005-2010
Figure 5: Over-the-Counter Drugs Market, Denmark, Revenue ($m), 2006-2010
Figure 6: Major Therapeutic Areas, Denmark, Revenue ($m), 2010
Figure 7: Nervous System Drugs Market, Denmark, Revenue ($m), 2006-2010
Figure 8: Anti-Cancer Drugs Market, Denmark, Revenue ($m), 2006-2010
Figure 9: Anti-Infectives Market, Denmark, Revenue ($m), 2006-2010
Figure 10: Respiratory Drugs Market, Denmark, Revenue ($m), 2006-2010
Figure 11: Gastrointestinal Drugs Market, Denmark, Revenue ($m), 2006-2010
Figure 12: Medical Device Market, Denmark, Revenue ($bn), 2006-2011
Figure 13: Medical Device Market, Denmark, Revenue Forecast ($bn), 2012-2020
Figure 14: Medical Device Market, Denmark, Segments, Revenue ($m), 2011
Figure 15: In-Vitro Diagnostics Market, Denmark, Revenue ($m), 2006-2011
Figure 16: In-Vitro Diagnostics Market, Denmark, Revenue Forecast ($m), 2012-2020
Figure 17: Sales Trends for Major Players, In-Vitro Diagnostics, Denmark, 2006-2010
Figure 18: Orthopedic Devices Market, Denmark, Revenue ($m), 2006-2011
Figure 19: Orthopedic Devices Market, Denmark, Revenue Forecast ($m), 2012-2020
Figure 20: Sales Trends for Major Players, Orthopedic Devices, Denmark, 2006-2011
Figure 21: Ophthalmic Devices Market, Denmark, Revenue ($m), 2006-2011
Figure 22: Ophthalmic Devices Market, Denmark, Revenue Forecast ($m), 2012-2020
Figure 23: Sales Trends for Major Players, Ophthalmic Devices, Denmark, 2006-2010
Figure 24: Diagnostic Imaging Devices Market, Denmark, Revenue ($m), 2006-2011
Figure 25: Diagnostic Imaging Devices Market, Denmark, Revenue Forecast ($m), 2012-2020
Figure 26: Sales Trends for Major Players, Diagnostic Imaging Devices, Denmark, 2006-2010
Figure 27: Cardiovascular Devices Market, Denmark, Revenue ($m), 2006-2011
Figure 28: Cardiovascular Devices Market, Denmark, Revenue Forecast ($m), 2012-2020
Figure 29: Sales Trends for Major Players, Cardiovascular Devices, Denmark, 2006-2011
Figure 30: Major Medical Device Companies, Denmark, Revenue ($m), 2010
Figure 31: Drivers and Barriers, Healthcare Market, Denmark, 2012
Figure 32: Healthcare System Financing, Denmark, 2012
Figure 33: Healthcare System Key Players, Denmark, 2012
Figure 34: Applications for General Reimbursement Approval, Denmark, 2008-2011
Figure 35: Healthcare Spending, Denmark, Out-of-Pocket Expenditure (%), 2005-2010
Figure 36: Change in Average Price of Drugs (%), Denmark, 2006-2011
Figure 37: Healthcare Administration, Denmark, 2012
Figure 38: National Procedure for Market Authorization, Denmark, 2012
Figure 39: Centralized Procedure for Market Authorization, Pre-Submission, EU, 2012
Figure 40: Centralized Procedure for Market Authorization, Pre-Opinion Phase, EU, 2012
Figure 41: Centralized Procedure for Market Authorization, Post-Opinion Phase, EU, 2012
Figure 42: Decentralized Procedure for Market Authorization, EU, 2012
Figure 43: Mutual Recognition Procedure for Market Authorization, EU, 2012
Figure 44: Conformity Assessment of Class I Medical Devices, EU, 2012
Figure 45: Conformity Assessment of Class IIa Medical Devices, EU, 2012
Figure 46: Conformity Assessment of Class IIb Medical Devices, EU, 2012
Figure 47: Conformity Assessment of Class III Medical Devices, EU, 2012
Figure 48: Major Healthcare Reforms, Denmark, 1995-2011
Figure 49: GDP per Capita ($), Denmark, 2006-2011
Figure 50: GDP Per Capita ($), Denmark, Forecast, 2012-2020
Figure 51: GDP ($bn), Denmark, 2006-2011
Figure 52: GDP ($bn), Denmark, Forecast, 2012-2020
Figure 53: GDP, Denmark, Annual Growth (%), 2006-2011
Figure 54: GNI per Capita ($), Denmark, 2006-2011
Figure 55: Average Consumer Price Index, Denmark, 2006-2011
Figure 56: Average Consumer Price, Denmark, Annual Change (%), 2006-2011
Figure 57: Average Consumer Price, Denmark, Annual Change (%), Forecast, 2012-2020
Figure 58: Currency Exchange Rate (DKK/$), Denmark, 2006-2011
Figure 59: Foreign Direct Investment ($bn), Denmark, 2006-2011
Figure 60: Foreign Exchange Reserves ($bn), Denmark, 2006-2011
Figure 61: Exports of Goods and Services ($bn), Denmark, 2006-2011
Figure 62: Imports of Goods and Services ($bn), Denmark, 2006-2011
Figure 63: General Government Structural Balance ($bn), Denmark, 2006-2011
Figure 64: General Government Structural Balance ($bn), Forecast, Denmark, 2012-2020
Figure 65: General Government Gross Debt (% of GDP), Denmark, 2005-2010
Figure 66: External Debt ($bn), Denmark, 2006-2011
Figure 67: Major Industries, Denmark, Gross Value Added ($bn), 2010-2011
Figure 68: Population (m), Denmark, 2006-2011
Figure 69: Population (m), Denmark, Forecast, 2012-2020
Figure 70: Urban and Rural Population, Denmark, Share (%), 2006-2011
Figure 71: Urban and Rural Population, Denmark, Share (%), Forecast, 2012-2020
Figure 72: Age Groups, Denmark, Population Distribution (%), 2006-2011
Figure 73: Age Groups, Denmark, Population Distribution (%), Forecast, 2012-2020
Figure 74: Births (per 1,000 Population), Denmark, 2006-2011
Figure 75: Mortality (per 1,000 Population), Denmark, 2006-2011
Figure 76: Major Causes of Mortality, Denmark, 2010
Figure 77: Infant Mortality, Denmark, Mortality Rate (per 1,000 Live Births), 2005-2010
Figure 78: Immunization Rate for DPT, Measles (%), Denmark, 2005-2010
Figure 79: Major Causes of Male Mortality, Denmark, 2010
Figure 80: Major Causes of Female Mortality, Denmark, 2010
Figure 81: Gender Ratio (M/F), Denmark, 2006-2011
Figure 82: Life Expectancy at Birth (Years), Denmark, 2005-2010
Figure 83: Life Expectancy at Birth (Years), Denmark, Forecast, 2011-2020
Figure 84: Students, Denmark, Gross Enrollment (%), 2005-2010
Figure 85: Unemployment Rate (%), Denmark, 2005-2010
Figure 86: Major Causes of Hospitalization, Denmark, Male Patients (per 1,000 Population), 2010
Figure 87: Major Causes of Hospitalization, Denmark, Female Patients (per 1,000 Population), 2010
Figure 88: Major Diseases, Denmark, DALYs (per 100,000 Population), 2004
Figure 89: Number of Hospitals, Denmark, 2005-2010
Figure 90: Diagnostic Equipment Units (per 1,000,000 Population), Denmark, 2006-2011
Figure 91: Hospital Beds (per 1,000 Population), Denmark, 2005-2010
Figure 92: Physicians (per 1,000 Population), Denmark, 2005-2010
Figure 93: CO2 Emissions (kilotons), Denmark, 2005-2010
Figure 94: PM10 (Micrograms per Cubic Meter), Denmark, 2005-2010
Figure 95: Healthcare Personnel (per 1,000 Population), Denmark, 2005-2010
Figure 96: Healthcare Expenditures (% of GDP), Denmark, 2005-2010
Figure 97: Healthcare Expenditures, Denmark, Share of Major Components (%), 2010
Figure 98: Healthcare Expenditures, Denmark, Public-Private Share (%), 2005-2010
Figure 99: R&D Expenditures ($bn), Denmark, 2006-2011
Figure 100: Opportunities and Challenges, Healthcare Market, Denmark, 2012

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos